Johnson & Johnson Shares New Insights on Nipocalim...
Category : Clinical Trial Update 5 June 2026New Data Highlights Potential Benefits for Patients With Higher Disease Activity Johnson & Jo...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Omnix Medical Advances OMN6 into Phase II Trial fo...
Category : Clinical Trial Update 5 June 2026Omnix Medical Reaches an Important Clinical Milestone Omnix Medical has announced an important st...
Lundbeck’s Bocunebart Shows Positive Results in Ph...
Category : Clinical Trial Update 5 June 2026A New Step Forward in Migraine Treatment Migraine is not just a normal headache. For many people, i...
European Commission Approves Aquipta for Acute Mig...
Category : Approval/Launch 4 June 2026AbbVie Expands the Role of Aquipta in Migraine Care Across Europe AbbVie has announced that the E...
MEDIPOST Secures FDA Agreement for Single Pivotal...
Category : Clinical Trial Update 4 June 2026A Major Step Forward for CARTISTEM® in the United States MEDIPOST has announced an important...
Latest Newsletter Post
-
Lundbeck’s Bocunebart Shows Positiv..
5 June 2026
-
Omnix Medical Advances OMN6 into Ph..
5 June 2026
-
Johnson & Johnson Shares New Insigh..
5 June 2026
-
MEDIPOST Secures FDA Agreement for..
4 June 2026
-
European Commission Approves Aquipt..
4 June 2026
